To enable efficient and compliant pharmaceutical manufacturing, the digital tide is on the rise in the industry

In recent years, the state is vigorously supporting the combination of "Internet +" and the pharmaceutical industry to further meet the people's demand for
convenient medical services.

In this context, digitalization and intellectualization have increasingly become an emerging force for the transformation and upgrading of China's medical system, and the integration and innovation of the pharmaceutical industry have gradually begun to become the current new trend
of the industry.

In order to achieve efficient pharmaceutical production, the digital tide is rising in the industry (Image source: Pharmaceutical Network) It is understood that Yunnan Baiyao has created a "digital three-seven industry platform" through the use of 5G, industrial Internet, big data, artificial intelligence, blockchain and other technologies, which can achieve "traceable sources, traceable destinations, and accountable responsibilities", and the whole process of production can be visualized
.

In addition, on July 23 this year, Yunnan Baiyao and Huawei Technologies Co.
, Ltd.
also signed the "Comprehensive Cooperation Agreement on Artificial Intelligence Drug R&D" in Fuzhou, Fujian Province, aiming to jointly promote the deep integration
of artificial intelligence technology and the big health industry market.

Some time ago, East Ejiao released the first half of the performance announcement, and the net profit increased by 106%
year-on-year.

It is worth mentioning that for the reasons for the growth of performance, it is clearly stated that the company closely follows the strategic main line with consumer demand as the core, continuously optimizes the product structure, and upgrades the product portfolio; In-depth implementation of customer-centric digital operation model, deepening category extension and innovation exploration, to achieve customer growth and performance improvement
.

In addition, China Resources Sanjiu also mentioned in the research activity on December 2 last year that the company has built a digital center and transformed traditional businesses to build new businesses, and has achieved initial results
.

At the same time, the company has also laid out intelligent manufacturing in its digital strategy, connecting the consumer side and the manufacturing end and the front-end traceability
of traditional Chinese medicine.

It expressed its desire to build a mature digital business model
through 2-3 years of hard work.

On the whole, digitalization has become a trend in the development of the pharmaceutical industry, which is bringing new technical means and development opportunities
for pharmaceutical research and sales.

It is worth mentioning that in recent years, in the context of domestic high-end pharmaceutical equipment gradually realizing domestic substitution and constantly breaking the monopoly of high-end pharmaceutical equipment by foreign countries, the pharmaceutical equipment industry is actually rising "digital" boom
.

For example, Chutian Technology has introduced new intelligent logistics equipment to meet efficient production requirements in hardware; In terms of software, Chutian Technology has the ability to develop and build intelligent warehousing and logistics systems, and is serving its downstream pharmaceutical companies
.

It is understood that Chutian has high requirements for the independent use of the warehouse management system, how to use a complete digital supply chain system to shorten the response time between all links in the supply chain; Managing the whole supply chain, including internal supply chain management, supply chain production plan coordination, logistics management, etc.
, reducing human dependence, achieving standardized management and efficient operation, is the key work
in front of Chutian.

In 2021, Chutian Technology put forward the request of introducing a digital supply chain system to transform the
logistics of the factory in conjunction with Chutian Feiyun and Chutianyuan Chuangxiang Tongtianxiao Software.

In addition, Canaan Technology, Dongfulong, etc.
have also made future plans
in digitalization.

Among them, Canaan Technology has made it clear that the next step will be to create a two-way "future factory" from the aspects of digital twin technology, intelligent production, digital management, network collaboration, personalized customization, etc.
, and the company will also strive to improve intelligent and complete line engineering design capabilities to provide users with more high value-added services
.

Dongfulong also said that it will adhere to the mission of "professional technology to serve human health", focusing on the development strategy of "systematization, internationalization and digital intelligence", and provide forward-looking and competitive system solutions for pharmaceutical equipment, food equipment, cell therapy equipment and other system solutions
for global customers.

In general, it has become a general trend for pharmaceutical companies to accelerate their development with the help of digitalization
.

At the same time, the industry expects that more and more pharmaceutical machinery companies will also use artificial intelligence, big data, digitalization and other technologies and platforms to help pharmaceutical companies accelerate drug research and development and production, and continuously contribute to the high-quality development of the pharmaceutical industry
.

Disclaimer: Under no circumstances does the information herein or the opinions expressed in this article constitute investment advice
to any person.